Company Filing History:
Years Active: 2020-2025
Title: The Innovative Contributions of Phillip M Schwartz
Introduction
Phillip M Schwartz is a notable inventor based in Jerusalem, IL, recognized for his significant contributions to pharmaceutical formulations. With a total of 3 patents, Schwartz has focused on developing innovative methods for oral administration of active agents, enhancing the efficacy of therapeutic treatments.
Latest Patents
Schwartz's latest patents include formulations for oral administration of active agents. One of his notable inventions involves pharmaceutical compositions that comprise a therapeutically active agent and an absorption enhancer, such as NAC, NAD, 5-CNAC, 4-MOAC, or 4-CNAB. These compositions are designed for the concomitant oral administration of multiple unit dosage forms, which together provide a therapeutically effective amount of the active agent and an effective amount of the absorption enhancer. Another significant patent details a pharmaceutical composition for oral administration that includes a therapeutically active agent, SNAC, and at least one antacid compound. This invention also describes a unit dosage form that consists of a core with the active agent and SNAC, along with an external layer containing protective agents like antacid compounds.
Career Highlights
Phillip M Schwartz is currently associated with Entera Bio Ltd., where he continues to innovate in the field of pharmaceutical sciences. His work focuses on improving the delivery and effectiveness of therapeutic agents through advanced formulations.
Collaborations
Schwartz collaborates with esteemed colleagues, including Gregory Burshtein and Ariel Rothner, contributing to a dynamic research environment that fosters innovation.
Conclusion
Phillip M Schwartz's work exemplifies the intersection of innovation and healthcare, as he continues to develop groundbreaking pharmaceutical compositions that enhance treatment efficacy. His contributions are vital in advancing the field of drug delivery systems.